Open Orphan plc changed its name to hVIVO plc on 26 October 2022, learn more
here
.
About Us
About hVIVO
Leadership Team
Our Companies
Key Stats
History
Services
Challenge Trials
RSV
Influenza
COVID-19
HRV
Malaria
Asthma & COPD
Laboratory Services
Assay Development
Field Trial Bio-logistics
Cell Based Assays
Molecular Services
Compound Efficacy & VRM
Biomarker Analysis
Phase II-III Clinical Trials
Vaccine Phase II-III Trials
Articles & Research
News & Media
Regulatory News
Media Coverage
Media Press Kit
Video Library
Events
Investors
New
Investors
Regulatory News & Email Alerts
Results Centre
Share Price Information
Events & Presentations
Environmental, Social & Governance
AIM Rule 26
Advisors
Documents
Corporate Governance
Volunteers
Careers
Contact Us
Contact Us
Articles & Research
from hVIVO
Article Types Filter
Article Types Filter
Blog
Article
Presentation
Scientific Paper
Factsheet
Case Study
Article Count
1 - 10 of 31 posts
Article
24 Nov 2022
Human Clinical Trials: A Tool in the Fight Against Infectious Diseases
International Clinical Trials, Autumn 2022, pages 94-97. © Samedan Ltd
View Link
Presentation
03 Oct 2022
RSV Vaccines/Prophylactics: Key learning from the RSV challenge model and efficacy of vaccines
View Link
Presentation
03 Oct 2022
Initial characteristics of respiratory viruses in symptomatic subjects during the pandemic, a cohort study
View Link
Presentation
03 Oct 2022
Immunomodulators and treatment of disease in the influenza human challenge model
View Link
Blog
24 Aug 2022
Human Challenge Studies: Their Conduct and Safety Aspects
If there would be a survey of 100 clinical research professionals either from CRO or from Pharma/Biotech industry to explain what a human challenge study is, the most common answer...
Read more
Scientific Paper
17 Aug 2022
Treatment with the P2X3-Receptor Antagonist Gefapixant for Acute Cough in Induced Viral Upper Respiratory Tract Infection: A Phase 2a, Randomized, Placebo-Controlled Trial
View Link
Case Study
16 Aug 2022
RSV Human Challenge Case Study
An international biotech company, headquartered in the EU approached hVIVO to explore the possibility of performing a RSV Phase IIa challenge study. The investigational product was a novel recombinant modified...
View Link
Blog
08 Jun 2022
Infectious Diseases Blog – ‘The Pathogenda’ Part 5
In one of the most important discoveries in medicine this year, Epstein-Barr virus (EBV) has been collared as the link/early causal role in multiple sclerosis. Finding the virus underpinning multiple...
Read more
Blog
19 May 2022
Infectious Diseases Blog – ‘The Pathogenda’ Part 4
So we know, or at least it is being widely reported, that depression and anxiety indices are raised worldwide, and most especially in High Income Countries (HIC). Whilst this is...
Read more
Scientific Paper
12 May 2022
Human infection studies: Key considerations for challenge agent development and production
View Link
Article Pagination
1
2
3
4
Articles Per Page
Articles Per Page
8
10
16
24
32
angle-down
meetup
chevron-down